Rodrigo Juan P, López Fernando, Llorente José L, Álvarez-Marcos César, Suárez Carlos
Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España; Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, España.
Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España; Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, España.
Acta Otorrinolaringol Esp. 2015 May-Jun;66(3):132-8. doi: 10.1016/j.otorri.2014.06.001. Epub 2014 Aug 4.
Total laryngectomy (TL) and postoperative radiotherapy (RT), when indicated, have proven to be effective in treating cases of locally advanced laryngeal cancer. The aim of this study was to analyse the oncological outcomes of this procedure in patients with laryngeal cancer classified T3 and T4a.
We studied 80 patients (51 T3 and 29 T4a) with primary squamous cell carcinoma of the larynx who underwent TL between 1998 and 2006. Bilateral neck dissection was performed in 54 patients, unilateral in 11, and central in 4. Twenty patients (25%) received postoperative radiotherapy.
Mean age was 64 years with a male predominance (97%). As for habits, 96% were smokers and 89% consumed alcohol. Lymph node metastases occurred in 44% of patients and extracapsular invasion in 37% of them. All cases had tumour-free margins. In all, 25% of patients had loco-regional recurrence and 5% developed distant metastases. The 5-year disease-specific survival was 72% and 5-year overall survival was 55%. Variables associated with decreased disease-specific survival were T4 classification (P=.068), N2-N3 classifications (P=.005), extracapsular invasion (P=.018) and stage iv disease (P=.009). On multivariate analysis, the only variable associated with decreased disease-specific survival was the presence of N2-N3 nodal metastases (P=.008).
TL is an effective treatment for the management of patients with locally advanced laryngeal cancer. Organ preservation protocols should achieve similar oncological results to those obtained with TL.
全喉切除术(TL)及术后放疗(RT)(如适用)已被证明在治疗局部晚期喉癌病例中有效。本研究的目的是分析该手术在T3和T4a期喉癌患者中的肿瘤学结局。
我们研究了1998年至2006年间接受TL的80例原发性喉鳞状细胞癌患者(51例T3期和29例T4a期)。54例患者行双侧颈清扫术,11例行单侧颈清扫术,4例行中央颈清扫术。20例患者(25%)接受了术后放疗。
平均年龄为64岁,男性占主导(97%)。就习惯而言,96%为吸烟者,89%饮酒。44%的患者发生淋巴结转移,其中37%有包膜外侵犯。所有病例切缘均无肿瘤。总体而言,25%的患者发生局部区域复发,5%发生远处转移。5年疾病特异性生存率为72%,5年总生存率为55%。与疾病特异性生存率降低相关的变量为T4分期(P = 0.068)、N2 - N3分期(P = 0.005)、包膜外侵犯(P = 0.018)和IV期疾病(P = 0.009)。多因素分析显示,与疾病特异性生存率降低相关的唯一变量是存在N2 - N3淋巴结转移(P = 0.008)。
全喉切除术是治疗局部晚期喉癌患者的有效方法。器官保留方案应取得与全喉切除术相似的肿瘤学结果。